China Meheco Group (600056) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

600056 China Meheco Group

Watchlist

10.62
0.000.00%

Not Open Jan 23 15:00 CST

15.89BMarket Cap17.64P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Meheco Unit's Flumazenil Injection Passes Consistency Evaluation
MT NewswiresJan 13 22:44 ET
CMB International: With continued policy efforts, Bullish on the rebound of China Meheco Group's valuation.
Benefiting from overseas interest rate cuts and improvements in the domestic macro environment, the pharmaceutical sector, as a high-elasticity Industry, is expected to outperform the market in 2025.
Zhitong FinanceJan 8 03:34 ET
China Meheco Group Co., Ltd.'s (SHSE:600056) Share Price Is Matching Sentiment Around Its Earnings
Simply Wall StJan 2 18:50 ET
Meheco Unit's Angina Tablets Passes Chinese Drug Regulator's Consistency Evaluation
MT NewswiresDec 23, 2024 01:40 ET
Meheco Unit's Sepsis Drug Included in China's Centralized Procurement Bid
MT NewswiresDec 16, 2024 00:01 ET
China Meheco Group (600056.SH): Sodium piperacillin for injection is expected to be selected for centralized procurement.
China Meheco Group (600056.SH) announced that on December 12, 2024, its subsidiary in Hainan...
Zhitong FinanceDec 13, 2024 06:13 ET

Comments

Moomoo AI

Feb 4, 2024 23:10

Market caution over stock due to lack of EPS growth. Recent sell-off could be an opportunity, worth checking for signs of long term growth trend.

Investors One-year Losses Continue as China Meheco Group (SHSE:600056) Dips a Further 9.1% This Week, Earnings Continue to Decline

Moomoo AI

Dec 24, 2023 19:26

China Meheco's lower P/E ratio, due to diminishing earnings, appears to be factored in by the market. With unimproved profitability and lack of positive future earnings surprises, share price may remain stagnant.

Earnings Working Against China Meheco Group Co., Ltd.'s (SHSE:600056) Share Price

Moomoo AI

Dec 3, 2023 19:09

China Meheco Group's shrinking earnings and low return on equity do not present an attractive investment prospect. Stakeholders may not benefit from retained profits due to the low ROE. The lower than average ROE and decreasing net income suggest possible issues in the company's operation.